Sensus Healthcare (SRTS) Competitors $3.20 -0.11 (-3.32%) Closing price 10/17/2025 04:00 PM EasternExtended Trading$3.21 +0.01 (+0.31%) As of 10/17/2025 04:20 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock SRTS vs. TLSI, CV, ELMD, KRMD, INFU, STIM, SKIN, PROF, SGHT, and AVRShould you be buying Sensus Healthcare stock or one of its competitors? The main competitors of Sensus Healthcare include TriSalus Life Sciences (TLSI), CapsoVision (CV), Electromed (ELMD), KORU Medical Systems (KRMD), InfuSystem (INFU), Neuronetics (STIM), Beauty Health (SKIN), Profound Medical (PROF), Sight Sciences (SGHT), and Anteris Technologies Global (AVR). These companies are all part of the "medical equipment" industry. Sensus Healthcare vs. Its Competitors TriSalus Life Sciences CapsoVision Electromed KORU Medical Systems InfuSystem Neuronetics Beauty Health Profound Medical Sight Sciences Anteris Technologies Global TriSalus Life Sciences (NASDAQ:TLSI) and Sensus Healthcare (NASDAQ:SRTS) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their institutional ownership, analyst recommendations, media sentiment, earnings, dividends, profitability, valuation and risk. Do analysts rate TLSI or SRTS? TriSalus Life Sciences presently has a consensus price target of $10.90, indicating a potential upside of 117.13%. Sensus Healthcare has a consensus price target of $8.00, indicating a potential upside of 150.00%. Given Sensus Healthcare's higher possible upside, analysts clearly believe Sensus Healthcare is more favorable than TriSalus Life Sciences.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score TriSalus Life Sciences 1 Sell rating(s) 0 Hold rating(s) 5 Buy rating(s) 2 Strong Buy rating(s) 3.00Sensus Healthcare 2 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.20 Is TLSI or SRTS more profitable? Sensus Healthcare has a net margin of -2.26% compared to TriSalus Life Sciences' net margin of -86.61%. TriSalus Life Sciences' return on equity of 0.00% beat Sensus Healthcare's return on equity.Company Net Margins Return on Equity Return on Assets TriSalus Life Sciences-86.61% N/A -116.50% Sensus Healthcare -2.26%-1.58%-1.41% Which has more volatility & risk, TLSI or SRTS? TriSalus Life Sciences has a beta of 0.47, meaning that its stock price is 53% less volatile than the S&P 500. Comparatively, Sensus Healthcare has a beta of 1.38, meaning that its stock price is 38% more volatile than the S&P 500. Do insiders and institutionals have more ownership in TLSI or SRTS? 2.6% of TriSalus Life Sciences shares are held by institutional investors. Comparatively, 25.3% of Sensus Healthcare shares are held by institutional investors. 27.5% of TriSalus Life Sciences shares are held by insiders. Comparatively, 8.9% of Sensus Healthcare shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth. Which has higher earnings and valuation, TLSI or SRTS? Sensus Healthcare has higher revenue and earnings than TriSalus Life Sciences. Sensus Healthcare is trading at a lower price-to-earnings ratio than TriSalus Life Sciences, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioTriSalus Life Sciences$29.43M8.51-$30.05M-$1.18-4.25Sensus Healthcare$41.81M1.26$6.65M-$0.06-53.33 Does the media prefer TLSI or SRTS? In the previous week, TriSalus Life Sciences had 3 more articles in the media than Sensus Healthcare. MarketBeat recorded 3 mentions for TriSalus Life Sciences and 0 mentions for Sensus Healthcare. TriSalus Life Sciences' average media sentiment score of 0.11 beat Sensus Healthcare's score of 0.00 indicating that TriSalus Life Sciences is being referred to more favorably in the media. Company Overall Sentiment TriSalus Life Sciences Neutral Sensus Healthcare Neutral SummaryTriSalus Life Sciences beats Sensus Healthcare on 9 of the 17 factors compared between the two stocks. Get Sensus Healthcare News Delivered to You Automatically Sign up to receive the latest news and ratings for SRTS and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding SRTS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart SRTS vs. The Competition Export to ExcelMetricSensus HealthcareMED INSTRUMENTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$52.61M$7.03B$6.13B$10.55BDividend YieldN/A1.16%5.72%4.83%P/E Ratio-53.3327.9085.7827.06Price / Sales1.2627.79612.92132.30Price / Cash7.4122.3225.8230.35Price / Book0.945.1512.226.58Net Income$6.65M$179.79M$3.33B$276.84M7 Day Performance-0.31%-0.16%0.67%-0.72%1 Month Performance2.89%1.97%6.88%2.16%1 Year Performance-51.88%1.75%58.88%34.63% Sensus Healthcare Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)SRTSSensus Healthcare2.2179 of 5 stars$3.20-3.3%$8.00+150.0%-51.9%$52.61M$41.81M-53.3340TLSITriSalus Life Sciences2.253 of 5 stars$4.59+6.3%$10.90+137.5%+19.8%$215.43M$29.43M-3.89106Short Interest ↑CVCapsoVisionN/A$4.67+4.7%$5.50+17.8%N/A$208.61MN/A0.0090Short Interest ↑ELMDElectromed3.3866 of 5 stars$24.55+1.9%$36.25+47.7%+5.2%$205.63M$64M32.73160KRMDKORU Medical Systems1.1435 of 5 stars$4.07-5.1%$4.63+13.6%+55.2%$198.35M$33.65M-45.2280News CoverageINFUInfuSystem3.9656 of 5 stars$9.22-0.1%$13.50+46.4%+28.2%$188.33M$139.89M153.69410Positive NewsShort Interest ↑STIMNeuronetics1.7204 of 5 stars$2.76-1.1%$7.00+153.6%+177.1%$184.49M$74.89M-2.44180SKINBeauty Health2.1293 of 5 stars$1.52+5.6%$2.81+85.0%-10.6%$182.63M$334.30M-5.431,030PROFProfound Medical1.6379 of 5 stars$5.98+1.9%$11.00+83.9%-28.6%$176.81M$10.68M-4.10150SGHTSight Sciences1.4795 of 5 stars$3.26+1.9%$4.33+32.9%-21.4%$167.58M$79.87M-3.40210Gap UpAVRAnteris Technologies Global1.7812 of 5 stars$4.45-3.5%$16.50+270.8%N/A$166.25M$2.70M0.00138Short Interest ↑Gap Down Related Companies and Tools Related Companies TLSI Alternatives CV Alternatives ELMD Alternatives KRMD Alternatives INFU Alternatives STIM Alternatives SKIN Alternatives PROF Alternatives SGHT Alternatives AVR Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:SRTS) was last updated on 10/20/2025 by MarketBeat.com Staff From Our PartnersGold surges past $3,600 … but this has beat gold by 1,000xGold has surged past $3,600 an ounce — up 45% in the past year — but one veteran metals analyst says the real ...Weiss Ratings | SponsoredThis Crypto Is Set to Explode in JanuaryCurious about crypto but still stuck scrolling endless threads? People who get in early aren’t just lucky—they...Crypto 101 Media | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | Sponsored$15 Fund: Turn Gold Boom into Real IncomeIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredStunning new initiative unfolding in the White House?what I just learned about what’s unfolding in the White House is truly stunning… And you need to see it for...Paradigm Press | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredAI's Next Magnificent SevenThe original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredOctober 16 Changes the Microchip Game — and InvestingWhile everyone's chasing the same AI plays, George Gilder is focused on something completely different. He ...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Sensus Healthcare, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Sensus Healthcare With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
